{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nurix Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"NRIX"},"Address":{"label":"Address","value":"1700 OWENS STREET,SUITE 205, SAN FRANCISCO, California, 94158, United States"},"Phone":{"label":"Phone","value":"+1 415 660-5320"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications."},"CompanyUrl":{"label":"Company Url","value":"http://www.nurixtx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Arthur T. Sands","title":"President, Chief Executive Officer & Director"},{"name":"Bev Benson","title":"Vice President & Head-Clinical Science"},{"name":"Buckley Kohlhauff","title":"Senior Vice President-Information Technology"},{"name":"Gwenn M. Hansen","title":"Chief Scientific Officer"},{"name":"Marine Champsaur","title":"Vice President & Head-Medical Affairs"},{"name":"Pasit Phiasivongsa","title":"Chief Technical Officer"},{"name":"Paula G. Oâ€™Connor","title":"Chief Medical Officer"},{"name":"Seema P. Rogers","title":"Vice President & Head-Clinical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}